External-Beam Radiation Therapy or Implant Radiation Therapy Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage I Endometrial Cancer - Full Text View

Sponsored by:	Commissie Voor Klinisch Toegepast Onderzoek
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00376844

Purpose

RATIONALE: External-beam radiation therapy uses high-energy x-rays to kill tumor cells. Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving external-beam radiation therapy or implant radiation therapy after surgery may kill any tumor cells that remain after surgery. Sometimes, after surgery, the tumor may not need more treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether radiation therapy is more effective than observation when given after surgery in treating stage I endometrial cancer.

PURPOSE: This randomized phase III trial is studying external-beam radiation therapy or implant radiation therapy to see how well they work compared with observation in treating patients who have undergone surgery for stage I endometrial cancer.

Condition	Intervention	Phase
Endometrial Cancer	Procedure: adjuvant therapy Procedure: brachytherapy Procedure: observation Procedure: radiation therapy	Phase III

MedlinePlus related topics: Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized
Official Title:	PORTEC-2, Postoperative Radiation Therapy for Endometrial Carcinoma - A Multicenter Randomised Phase III Trial Comparing External Beam Radiation and Vaginal Brachytherapy

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Rate of locoregional relapse at 5 years [ Designated as safety issue: No ]
Rate of distant metastases at 5 years [ Designated as safety issue: No ]
Overall survival rate [ Designated as safety issue: No ]
Prognostic factors for relapse and morbidity [ Designated as safety issue: No ]

Estimated Enrollment:	104
Study Start Date:	May 2006

Detailed Description:

OBJECTIVES:

Compare the rate of 5-year locoregional relapse in patients undergoing external-beam radiotherapy or vaginal brachytherapy vs observation only after surgery for stage I endometrial cancer.
Compare 5-year rate of distant metastases in these patients.
Determine overall survival rate in these patients.
Determine prognostic factors for relapse and morbidity.

OUTLINE: This is a randomized, multicenter study. Patients are randomized to 1 of 2 treatment arms.

Arm I: Patients undergo either vaginal brachytherapy or external-beam radiotherapy.
Arm II: Patients are observed and undergo no further treatment. After completion of study treatment, patients are followed for approximately 83 days.

PROJECTED ACCRUAL: A total of 104 patients will be accrued for this study.

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Diagnosis of stage I endometrial cancer meeting 1 of the following criteria:
- Grade 1 or 2 with deep (≥ 50%) myometrial invasion (stage IC)
- Grade 2 or 3 with superficial (< 50%) myometrial invasion (stage IB)
No grade 3 endometrial carcinoma with deep myometrial invasion
Total abdominal hysterectomy and bilateral salpingo-oophorectomy required prior to randomization

PATIENT CHARACTERISTICS:

Menopausal status not specified

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00376844

Locations

Netherlands
Leiden University Medical Center
Leiden, Netherlands, 2300 RC

Sponsors and Collaborators

Commissie Voor Klinisch Toegepast Onderzoek

Investigators

Study Chair:

Carien C. L. Creutzberg, MD, PhD

Leiden University Medical Center

More Information

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

Study ID Numbers:	CDR0000502033, CKTO-2001-04, EU-20508
Study First Received:	September 13, 2006
Last Updated:	July 23, 2008
ClinicalTrials.gov Identifier:	NCT00376844
Health Authority:	United States: Federal Government

Keywords provided by National Cancer Institute (NCI):

stage I endometrial carcinoma

Study placed in the following topic categories:

Genital Diseases, Female
Endometrial Neoplasms
Genital Neoplasms, Female
Uterine Diseases

Uterine Neoplasms
Urogenital Neoplasms
Endometrial cancer
Carcinoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009